Healthcare / Medical Care FacilitiesTokyo
$1184.00
-3.00 (-0.25%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 10%
FCF escenarios
weak_data · normalized FCF $68.0M · quality 13.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5.3B
P/E
13.4x
↓EV/EBITDA
11.6x
↓ROE
17.8%
↑Gross Margin
10.1%
↓Debt/Equity
3.19
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+18.2%
FCF CAGR
—
FCF margin
0.4%
FCF / Net income
0.19x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $19.20B · net income $365.6M · FCF $68.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $19.20B | $19.20B | $16.66B | $13.69B | $11.63B |
| Net Income | $365.6M | $365.6M | $189.3M | $91.7M | $408.0M |
| EBITDA | $885.7M | $885.7M | $791.1M | $657.2M | $1.02B |
| EPS | 81.70 | 81.70 | 42.39 | 20.15 | 90.13 |
| Gross Margin | 10.1% | 10.1% | 8.7% | 9.3% | 11.5% |
| Operating Margin | 1.8% | 1.8% | -0.5% | -1.7% | 4.2% |
| Net Margin | 1.9% | 1.9% | 1.1% | 0.7% | 3.5% |
| Balance Sheet | |||||
| Debt/Equity | 3.19 | 3.19 | 3.60 | 4.74 | 5.08 |
| Current Ratio | 1.35 | 1.35 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $68.0M | $68.0M | $878.3M | $-770.8M | $-726.7M |
| Returns | |||||
| ROE | 17.8% | 17.8% | 11.4% | 6.2% | 30.3% |
| Valuation | |||||
| P/E | 13.36 | 13.36 | 24.30 | 74.44 | 25.42 |
| EV/EBITDA | 11.57 | 11.57 | 11.95 | 18.14 | 15.20 |
| P/B | 2.58 | 2.58 | 2.77 | 4.64 | 7.70 |
| Growth & Yield | |||||
| Revenue Growth | 15.3% | 15.3% | 21.7% | 17.8% | — |
| EPS Growth | 92.7% | 92.7% | 110.4% | -77.6% | — |
| Dividend Yield | 0.8% | 0.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
8.7%
EPS terminal req.
$105.06
Spread vs growth
84.0%
5Y implied EPS CAGR
9.2%
EPS terminal req.
$127.12
Spread vs growth
83.5%
10Y implied EPS CAGR
9.6%
EPS terminal req.
$204.73
Spread vs growth
83.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+20.2%
Start / end P/E
23.4x → 14.5x
EPS bridge
42.39 → 81.70
Residual
-35.3%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.